Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Cartilage Repair After Hip Microfracture
NCT04212650Phase 2Terminated
- Sponsor
- Steadman Philippon Research Institute
- Start
- Aug 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of losartan in chondropathy and fibrosis, sponsored by Steadman Philippon Research Institute. Primary endpoint: Treatment-Emergent Adverse Events at 18 months. Started Aug 2020; status: terminated.
02
Drugs
losartan
03
Conditions
chondropathyfibrosis
Beyond the preview
Go deeper on NCT04212650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04212650.